Gabatarwa A cikin ilimin cututtukan daji, immunotherapy ya fito azaman hanyar majagaba, yin amfani da tsarin garkuwar jiki don yaƙar cutar sankarau. Akwai hanyoyin rigakafi da yawa, amma Chimeric Antigen Rece.
Satumba 2022: Hukumar Tarayyar Turai (EC) ta ba da izinin Kite's CAR T-cell therapy Tecartus® (brexucabtagene autoleucel) don kula da manya marasa lafiya masu shekaru 26 da haihuwa tare da sake dawowa ko refractory (r/r) B-cell precurs.
Oktoba 2021: Brexucabtagene autoleucel (Tecartus, Kite Pharma, Inc.) Hukumar Abinci da Magunguna ta amince da ita ga manya marasa lafiya da suka koma ko tantanin halitta B-cell precursor m lymphoblastic leukemia (ALL). A cikin..
Yuli 2021: Duba sabbin magunguna a cikin maganin cutar kansa. Kowace shekara, bayan nazarin gwaje-gwajen da wasu muhimman abubuwa, USFDA ta amince da kwayoyi, don haka masu ciwon daji za su iya gaskata cewa magani ya kusa. ..